Investment bankers are gearing up for a pickup in dealmaking activity in global equity capital markets this year, buoyed by a ...
Odyssey Therapeutics is a promising biotech firm poised for IPO success with a focus on inflammatory and autoimmune diseases ...
Achieving IPO readiness goes beyond executing on the IPO transaction itself. In this guest commentary Nithya B. Das of ...
According to Nasdaq’s data, the U.S. saw 179 non-SPAC IPOs in 2024 – the most since 2021, and a 40% increase over 2023 (127). By value raised (ex SPACs), it was an even better year, with value raised ...
Klarna announced a distribution agreement with Stripe on Tuesday. The deal brings its BNPL services to Stripe's merchants in ...
Titan America SA (TTAM) has filed to raise $100 million in an IPO of its common shares, according to an SEC F-1 registration ...
After a two-and-a-half-year lull in SPAC activity, the second half of 2024 brought glimmers of sunshine to the otherwise ...
The deal will let Klarna offer its popular buy now, pay later plans to merchants using Stripe’s payment tools in 26 countries ...
As a result, Renaissance expects a banner year for IPOs, with an estimated volume range of 155 to 195 IPOs in 2025 and $40 ...